Wed, October 5, 2011
[ Wed, Oct 05th 2011 ] - Market Wire
MURRAY FRANK LLP Announces Investigation of Pharmaceutical Product Development, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of DaVita, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Voclosporin study published in the American Journal of Transplantation
[ Wed, Oct 05th 2011 ] - Market Wire
OncoSec Releases Devices for Use in Clinical Trials
[ Wed, Oct 05th 2011 ] - Market Wire
Inovio Pharmaceuticals' Synthetic Vaccine for Can .. ost Promising Research at Global Vaccine Congress
Tue, October 4, 2011
[ Tue, Oct 04th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Announces Inve .. ation of Pharmaceutical Product Development, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates DaVita, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
POZEN Provides Patent Litigation and Financial Guidance Update
[ Tue, Oct 04th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Neurocrine Biosciences Receives Second Milestone .. $20 Million Under Abbott Collaboration Agreement
[ Tue, Oct 04th 2011 ] - Market Wire
Investigation of Pharmaceutical Product Developme .. oldfarb Branham Law Firm LLP for Potential Shareh
[ Tue, Oct 04th 2011 ] - Market Wire
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
[ Tue, Oct 04th 2011 ] - Market Wire
Initial Data from Bio-Path Holdingsa? Phase I Cli .. entation at American Society of Hematology Annual
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Inve .. tion of Pharmaceuticals Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Por segundo ao consecutivo, el Humana Walmart-Pre .. a prima mensual ms baja en los 50 estados y en Wa
[ Mon, Oct 03rd 2011 ] - Market Wire
Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results
[ Mon, Oct 03rd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces I .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Pharmaceutical Product Development
[ Mon, Oct 03rd 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Annou .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Medwell Capital to Adopt IFRS
[ Mon, Oct 03rd 2011 ] - Market Wire
Allegiance Completes Private Placement Of 229,166 Common At $0.48 Per Share
Sun, October 2, 2011
[ Sun, Oct 02nd 2011 ] - Market Wire
HeartWare Reports Additional Clinical Data From B .. nued Access Patients at the 25th European Associa
Sat, October 1, 2011
[ Sat, Oct 01st 2011 ] - Market Wire
HealthSpring Unveils 2012 Medicare Advantage Plans
Fri, September 30, 2011
[ Fri, Sep 30th 2011 ] - Market Wire
AxoGen, Inc. Announces Completion of Merger, Name Change and Executive Team Changes
[ Fri, Sep 30th 2011 ] - Market Wire
Health Management Associates, Inc. Completes the .. alth Partners from Catholic Health Partners, Inc.
[ Fri, Sep 30th 2011 ] - Market Wire
Merck Announces New Data Analyses for VICTRELISa" .. ed at The American Association for the Study of L
[ Fri, Sep 30th 2011 ] - Market Wire
Vertex to Present New Data from Hepatitis C Development Program at AASLD Annual Meeting
[ Fri, Sep 30th 2011 ] - Market Wire
Reminding Seniors to Be Mindful of Medications
[ Fri, Sep 30th 2011 ] - Market Wire
Merck to Hold Third-Quarter 2011 Sales and Earnings Conference Call on October 28
[ Fri, Sep 30th 2011 ] - Market Wire
A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[ Fri, Sep 30th 2011 ] - Market Wire
ShangPharma to Attend Upcoming Investor Conferences in October
[ Fri, Sep 30th 2011 ] - Market Wire
Concord Medical Services Announces Share Repurchase Program
Thu, September 29, 2011
[ Thu, Sep 29th 2011 ] - Market Wire
Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial
[ Thu, Sep 29th 2011 ] - Market Wire
Biogen Idec bevordert Tony Kingsley tot hoofd van Global Commercial Operations
[ Thu, Sep 29th 2011 ] - Market Wire
Galectin Therapeutics Posts New Corporate Presentation Video to its Website
[ Thu, Sep 29th 2011 ] - Market Wire
SANUWAVE Appoints Private Equity Veteran Barbara M. Henagan to Its Board of Directors
[ Thu, Sep 29th 2011 ] - Market Wire
The National Association Of Boards Of Pharmacy An .. Patients About The Flood Of Counterfeit Medicines
[ Thu, Sep 29th 2011 ] - Market Wire
Federal Fire Department in Pearl Harbor Uses ZOLL .. ave 37-Year-Old Seaman from Sudden Cardiac Arrest
[ Thu, Sep 29th 2011 ] - Market Wire
NanoViricides Inc Files For Extension of Form 10-K Annual Report Submission Date
[ Thu, Sep 29th 2011 ] - Market Wire
Illumina Introduces Low-Cost Bovine BeadChip for Genotyping of Dairy Cattle
[ Thu, Sep 29th 2011 ] - Market Wire
Chronic Conditions Cost UK Economy More Than 20 Billion Pounds a Year
Wed, September 28, 2011
[ Wed, Sep 28th 2011 ] - Market Wire
Five Days Remain before Deadline in Class-action Lawsuit against Dendreon, Says Hagens Berman
[ Wed, Sep 28th 2011 ] - Market Wire
HeartWare Announces Presentation of Clinical Data .. tion for Cardio-Thoracic Surgery (EACTS) Annual M
[ Wed, Sep 28th 2011 ] - Market Wire
BioDelivery Sciences Announces Results from Phase .. cacy Study for BEMA Buprenorphine in Chronic Pain
[ Wed, Sep 28th 2011 ] - Market Wire
Experts to Provide Successful Strategies for Glob .. ent and Commercialization at PAREXEL Tokyo Semina
[ Wed, Sep 28th 2011 ] - Market Wire
Boston Scientific Announces Favorable Appellate C .. ming Non-Infringement of Johnson & Johnson Patent
[ Wed, Sep 28th 2011 ] - Market Wire
Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals
[ Wed, Sep 28th 2011 ] - Market Wire
IntegraMed Promotes Tim Sheehan to SVP and CFO
[ Wed, Sep 28th 2011 ] - Market Wire
ImmunoCellular Therapeuticsa? ICT-107 Recognized .. hovera?s Top 10 Most Licensable Oncology Products
[ Wed, Sep 28th 2011 ] - Market Wire
Amyris e Michelin Anunciam Colaborao para Desenvolver e Comercializar Isopreno de Fontes Renovveis
Tue, September 27, 2011
[ Tue, Sep 27th 2011 ] - Market Wire
Gallup und Healthways verffentlichen erste Ergebn .. s Well-Being (Wohlbefindens)-Index fr Deutschland
[ Tue, Sep 27th 2011 ] - Market Wire
HCA Announces Proposed Public Offering of $500 Million Senior Notes
[ Tue, Sep 27th 2011 ] - Market Wire
Catasys Launches Its Integrated Substance Dependence Program in Massachusetts
[ Tue, Sep 27th 2011 ] - Market Wire
Merck Names Cuong Viet Do as Chief Strategy Officer
[ Tue, Sep 27th 2011 ] - Market Wire
POZEN Announces October 4, 2011 Mid-Quarter Update and Financial Guidance Webcast
[ Tue, Sep 27th 2011 ] - Market Wire
BioLineRx to Present Data from the Successfully C .. L-1020 at European Conference on Schizophrenia Re
[ Tue, Sep 27th 2011 ] - Market Wire
Molina Healthcare Names Michael Steele as Senior Vice President of Dual Eligible Strategies
[ Tue, Sep 27th 2011 ] - Market Wire
Alexion recibe opinin positiva del CHMP para Soli .. s con sndrome ur©mico hemoltico atpico (aHUS) en
[ Tue, Sep 27th 2011 ] - Market Wire
Evidence of AT13387 Activity in Gastrointestinal Stromal Tumor Models Presented at ECCO
Mon, September 26, 2011
[ Mon, Sep 26th 2011 ] - Market Wire
Guidance For Cannabis Science Brand Products To B .. lorado Based On Accumulating Anecdotal Reports Of
[ Mon, Sep 26th 2011 ] - Market Wire
Health Net Sponsors 2011 Congressional Medal of Honor Convention and Star-Studded Tribute Concert
[ Mon, Sep 26th 2011 ] - Market Wire
Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device
[ Mon, Sep 26th 2011 ] - Market Wire
Alnylam Initiates Phase I Clinical Study of ALN-P .. ting PCSK9 for the Treatment of Severe Hyperchole
[ Mon, Sep 26th 2011 ] - Market Wire
Synta Announces Presentation of Results of Ganete .. udy in Combination with Docetaxel in Solid Tumors
[ Mon, Sep 26th 2011 ] - Market Wire
iCo Therapeutics and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema
[ Mon, Sep 26th 2011 ] - Market Wire
ARIAD Announces Long-Term Follow Up of Patients w .. stant CML Treated with Ponatinib in Phase 1 Trial
[ Mon, Sep 26th 2011 ] - Market Wire
Millennium y Seattle Genetics presentan datos cln .. uximab Vedotin) en pacientes peditricos en reunin
[ Mon, Sep 26th 2011 ] - Market Wire
National Hospice and Palliative Care Expert Joins Amedisys
Sat, September 24, 2011
[ Sat, Sep 24th 2011 ] - Market Wire
FDA lsst Soliris® (Eculizumab) zur Behandlung al .. atypischem hmolytisch-urmischem Syndrom (aHUS) zu
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium en Seattle Genetics presenteren klinis .. brentuximab vedotin) bij pediatrische patinten op
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, la?oc .. de la?EMCC, des donn©es cliniques concernant la?
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium und Seattle Genetics legen auf der EMC .. n zu ADCETRISa" (Brentuximab Vedotin) bei pdiatri
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent la?occ .. e la?EMCC des donn©es cliniques concernant la?ut
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, .. occasion de la r©union annuelle de la?EMCC,&#
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium and Seattle Genetics Present Clinical .. mab Vedotin) in Pediatric Patients at EMCC Annual
Fri, September 23, 2011
[ Fri, Sep 23rd 2011 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.
[ Fri, Sep 23rd 2011 ] - Market Wire
Soliris (eculizumab) goedgekeurd door FDA voor al .. met atypisch hemolytisch uremisch syndroom (aHUS)
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene: reglementaire update inzake REVLIMID
[ Fri, Sep 23rd 2011 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Investigation of American Medical Alert Corp.
[ Fri, Sep 23rd 2011 ] - Market Wire
European CHMP Adopts Positive Opinion for Evipler .. Tablet Regimen for the Treatment of HIV Infection
[ Fri, Sep 23rd 2011 ] - Market Wire
MISE JOUR RGLEMENTAIRE DE CELGENE AU SUJET DE REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene prsentiert aktuelle Informationen zur Marktzulassung von REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
AGGIORNAMENTO REGOLATORIO DI CELGENE CIRCA REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene Regulatory Update on REVLIMID®
Thu, September 22, 2011
[ Thu, Sep 22nd 2011 ] - Market Wire
Enzon Announces Reduction in Force to Align Operations with Research and Development Activities
[ Thu, Sep 22nd 2011 ] - Market Wire
U.S. Physical Therapy to Present at The Sixth Annual JMP Securities Healthcare Conference
[ Thu, Sep 22nd 2011 ] - Market Wire
U.S. Physical Therapy to Present at the The Sixth Annual JMP Securities Healthcare Conference
[ Thu, Sep 22nd 2011 ] - Market Wire
Brain Resource Opens U.S. Headquarters in San Francisco
[ Thu, Sep 22nd 2011 ] - Market Wire
PFCD Hill Briefing Demonstrates How Health Indices Promote Prevention and Improve Overall Health
[ Thu, Sep 22nd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Dendreon Corporation
[ Thu, Sep 22nd 2011 ] - Market Wire
dermaPACE Pivotal Phase III Clinical Trial Data i .. r Healing to Be Presented at Plastic Surgery 2011
[ Thu, Sep 22nd 2011 ] - Market Wire
Columbia Laboratories Extends Stockholder Rights .. rve Use of Net Operating Losses under Section 382
[ Thu, Sep 22nd 2011 ] - Market Wire
The Future of Ablation Therapies Conference
Wed, September 21, 2011
[ Wed, Sep 21st 2011 ] - Market Wire
Less Than Two Weeks Remain before Deadline in Cla .. tion Lawsuit against Dendreon, Says Hagens Berman
[ Wed, Sep 21st 2011 ] - Market Wire
Osiris Therapeutics to Present at the Sixth Annual JMP Securities Healthcare Conference
[ Wed, Sep 21st 2011 ] - Market Wire
Health Net Announces Appearance at Credit Suisse 2nd Annual Small & Mid Cap Conference
[ Wed, Sep 21st 2011 ] - Market Wire
Alnylam to Webcast Presentation at the JMP Securities Healthcare Conference
[ Wed, Sep 21st 2011 ] - Market Wire
ACADIA Pharmaceuticals to Present at the Sixth An .. ities Healthcare Conference on September 28, 2011
[ Wed, Sep 21st 2011 ] - Market Wire
ARIAD Announces Start of Enrollment in Phase 1/2 .. 3, an Investigational Dual Inhibitor of ALK and E
[ Wed, Sep 21st 2011 ] - Market Wire
Celgene Corporation to Present at JMP Securities Healthcare Conference 2011
[ Wed, Sep 21st 2011 ] - Market Wire
Independent Proxy Advisory Firms ISS and Glass Le .. hareholders Vote in Favour of Plan of Arrangement
[ Wed, Sep 21st 2011 ] - Market Wire
Smith & Nephew Introduces New Hysteroscopic Morce .. on Simulator Designed to Enhance Surgeon Training
Tue, September 20, 2011
[ Tue, Sep 20th 2011 ] - Market Wire
Jury Awards Medtronic $101 Million in Patent Suit against NuVasive
[ Tue, Sep 20th 2011 ] - Market Wire
Manny Villafaa Discusses FDA Update for Kips Bay Medical
[ Tue, Sep 20th 2011 ] - Market Wire
St. Jude Medical meldt Europese introductie van kleiner quadripolair pacingsysteem
[ Tue, Sep 20th 2011 ] - Market Wire
??????????????,?52???,2???????????????????ONGLYZAa" (????)???????(HbA1c)??
[ Tue, Sep 20th 2011 ] - Market Wire
St. Jude Medical annuncia il lancio in Europa di .. i stimolazione quadripolare di dimensioni ridotte
[ Tue, Sep 20th 2011 ] - Market Wire
Merck Joins Global Fight to Help Save Women's Lives During Pregnancy and Childbirth
[ Tue, Sep 20th 2011 ] - Market Wire
Pfizer Announces Expiration of Subsequent Offerin .. letion of Tender Offer for Shares of Icagen, Inc.
[ Tue, Sep 20th 2011 ] - Market Wire
Centric Health to Acquire Medical Imaging Centres Inc. and Rads 24/7 Teleradiology Consultants
[ Tue, Sep 20th 2011 ] - Market Wire
Covidien to Present at Jefferies 2011 Global Healthcare Conference
Mon, September 19, 2011
[ Mon, Sep 19th 2011 ] - Market Wire
Alere Acquires Additional Shares of Axis-Shield
[ Mon, Sep 19th 2011 ] - Market Wire
NeuroMetrix Reports Product Milestone
[ Mon, Sep 19th 2011 ] - Market Wire
Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer
[ Mon, Sep 19th 2011 ] - Market Wire
FDA Panel to Review AtriCurea?s Synergy Ablation System on October 26
[ Mon, Sep 19th 2011 ] - Market Wire
Inhibitex Commences Dosing of Phase 2 Clinical Tr .. of INX-189 in HCV Infected Genotype 2/3 Patients
[ Mon, Sep 19th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) (saxagliptina) adicionado .. abetes tipo 2 manteve redues nos nveis de acar no
[ Mon, Sep 19th 2011 ] - Market Wire
Extensin de un estudio en fase de investigacin de .. liptina) incorporado a la insulina en adultos con
[ Mon, Sep 19th 2011 ] - Market Wire
Cord Blood America Updates Investors on Laboratory Licensing
Sun, September 18, 2011
[ Sun, Sep 18th 2011 ] - Market Wire
Sangamo BioSciences Announces Presentation of Gro .. a From ZFN Therapeutic for HIV/AIDS at ICAAC 2011
Sat, September 17, 2011
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d'une ©tude exp .. ptine) plus insuline chez les patients adultes at
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d'une ©tude exp .. tine) plus insuline chez les patients adultes att
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d';&# .. 4;;; ONGLYZAa" (saxagliptine) plus insu
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d';&# .. ntale,;;;;; ONGLYZAa" (saxagli
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
Fri, September 16, 2011
[ Fri, Sep 16th 2011 ] - Market Wire
Misonix Schedules Fourth Quarter and Year-End Fis .. nference Call;; September 20, 2011 at 4:30
[ Fri, Sep 16th 2011 ] - Market Wire
NPS Pharmaceuticals Highlights Hypoparathyroidism .. al Meeting of American Society for Bone and Miner
[ Fri, Sep 16th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) toegevoegd aan insuline b .. ype 2 bood duurzame verlaging van het bloedsuiker
[ Fri, Sep 16th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) When Added to Insulin in .. aintained Reductions in Blood Sugar Levels (HbA1c
[ Fri, Sep 16th 2011 ] - Market Wire
BioLineRx to Present at Annual UBS Global Life Sciences Conference in New York on September 21st
[ Fri, Sep 16th 2011 ] - Market Wire
New data for once-daily linagliptin show durable efficacy over two years
[ Fri, Sep 16th 2011 ] - Market Wire
Centene Corporation Elects Orlando Ayala of Microsoft to Board of Directors
[ Fri, Sep 16th 2011 ] - Market Wire
Jazz Pharmaceuticals Announces Presentation at th .. e Sciences Conference in New York on September 20
Thu, September 15, 2011
[ Thu, Sep 15th 2011 ] - Market Wire
Covidien kondigt O&O-centrum in China aan
[ Thu, Sep 15th 2011 ] - Market Wire
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
[ Thu, Sep 15th 2011 ] - Market Wire
Covidien Announces R&D Center in China
[ Thu, Sep 15th 2011 ] - Market Wire
Covidien construye centro de investigacin y desarrollo en China
[ Thu, Sep 15th 2011 ] - Market Wire
BioLineRx Announces European Confirmation of Medi .. for BL-5010, for Non-surgical Removal of Skin Le
[ Thu, Sep 15th 2011 ] - Market Wire
Cubist Antibiotic Programs Featured in 49 Presentations at 51st ICAAC
[ Thu, Sep 15th 2011 ] - Market Wire
Cord Blood America CEO Statement to Shareholders
[ Thu, Sep 15th 2011 ] - Market Wire
ShangPharma Subsidiary and Jiangsu Hengrui Medici .. in Therapeutic Antibody Research and Development
Wed, September 14, 2011
[ Wed, Sep 14th 2011 ] - Market Wire
Vanda Pharmaceuticals to Participate in UBS Global Life Sciences Conference
[ Wed, Sep 14th 2011 ] - Market Wire
Le New England Journal of Medicine publie des don .. MINATE da?INCIVEKMC (T©lapr©vir) sur la?h©pati
[ Wed, Sep 14th 2011 ] - Market Wire
Thirty-Five Health Management Hospitals Named Top .. s on Key Quality Measures by the Joint Commission
[ Wed, Sep 14th 2011 ] - Market Wire
Greatbatch, Inc. to Participate in the UBS Global Life Sciences Conference
[ Wed, Sep 14th 2011 ] - Market Wire
HealthSpring Among Fortunea?s 100 Fastest Growing Companies
[ Wed, Sep 14th 2011 ] - Market Wire
PPD Named to InformationWeek 500 List of U.S. Business Technology Innovators
[ Wed, Sep 14th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at UBS Global Life Sciences Conference on September 21st
[ Wed, Sep 14th 2011 ] - Market Wire
Medtronic Pledges Action in Advance of United Nat .. ns High Level Meeting on Noncommunicable Diseases
Tue, September 13, 2011
[ Tue, Sep 13th 2011 ] - Market Wire
InterMune Announces Pricing of Concurrent Public .. of Common Stock and $135 Million Principal Amoun
[ Tue, Sep 13th 2011 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. ation at Bank of America Merrill Lynch Conference
[ Tue, Sep 13th 2011 ] - Market Wire
iCo Therapeutics CEO to Present &;; Act as .. nnual Drug Repositioning and Pipeline Enhancement
[ Tue, Sep 13th 2011 ] - Market Wire
LabCorp';s Zero Coupon Convertible Su .. ated Notes Due 2021 to Accrue Contingent Interest
[ Tue, Sep 13th 2011 ] - Market Wire
Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen,;; Inc.
[ Tue, Sep 13th 2011 ] - Market Wire
Compugen Announces Validation of Two Immune System Modulating Drug Candidates
[ Tue, Sep 13th 2011 ] - Market Wire
Seattle Genetics and Oxford BioTherapeutics to Collaborate on Antibody-Drug Conjugates for Cancer
[ Tue, Sep 13th 2011 ] - Market Wire
BioLineRx Announces Positive Preliminary Results .. I Clinical Trial of BL-1021 for Neuropathic Pain
Mon, September 12, 2011
[ Mon, Sep 12th 2011 ] - Market Wire
Dr. Mark Freedman to Join Opexaa?s Scientific Advisory Board
[ Mon, Sep 12th 2011 ] - Market Wire
New Research Indicates Treating Neonatal Respirat .. OSURF® Results in Lower Rate of Mortality Compar
[ Mon, Sep 12th 2011 ] - Market Wire
BioSante Pharmaceuticals Successfully Completes LibiGel® Pharmacokinetic Study
[ Mon, Sep 12th 2011 ] - Market Wire
InVivo Therapeutics Promotes Lauren Mitarotondo t .. ; Operations as InVivo Prepares for Human Studies
[ Mon, Sep 12th 2011 ] - Market Wire
Geron to Webcast Presentations at Upcoming Investor Conferences
[ Mon, Sep 12th 2011 ] - Market Wire
Curis Announces Submission of New Drug Applicatio .. h for Vismodegib in Advanced Basal Cell Carcinoma
[ Mon, Sep 12th 2011 ] - Market Wire
Tenet Refines 2011 Outlook in Advance of Investor Meetings
[ Mon, Sep 12th 2011 ] - Market Wire
SuperGen,;; Inc. Changes Name to Astex .. Inc.,;; Announces New Stock Ticker Symb
Sun, September 11, 2011
[ Sun, Sep 11th 2011 ] - Market Wire
Panmira und FLAP LLCs als Ausgrndungen von Amira Pharmaceuticals entstanden
Sat, September 10, 2011
[ Sat, Sep 10th 2011 ] - Market Wire
Questcor Provides Updated New Paid Prescription Trends
[ Sat, Sep 10th 2011 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. cast of Presentation at Morgan Stanley Conference
[ Sat, Sep 10th 2011 ] - Market Wire
Electromed,;; Inc. Fourth Quarter and Y .. Call Scheduled for September 13,;; 2011
[ Sat, Sep 10th 2011 ] - Market Wire
Exelixis Announces Webcasts of Upcoming Investor Conference Presentations
[ Sat, Sep 10th 2011 ] - Market Wire
Panmira y FLAP LLCs realizan una desinversin de Amira Pharmaceuticals
Fri, September 9, 2011
[ Fri, Sep 09th 2011 ] - Market Wire
Panmira und FLAP LLCs als Ausgrndungen von Amira Pharmaceuticals entstanden
[ Fri, Sep 09th 2011 ] - Market Wire
China Sky One Medical Announces Change of Board Directors
[ Fri, Sep 09th 2011 ] - Market Wire
Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
[ Fri, Sep 09th 2011 ] - Market Wire
Boston Scientific Issues Statement Regarding FDA .. Surgical Mesh to Treat Pelvic Organ Prolapse and
[ Fri, Sep 09th 2011 ] - Market Wire
Positive Results from Phase 2 Clinical Study of N .. Cancer Presented in Oral Session at the ASCO 2011
[ Fri, Sep 09th 2011 ] - Market Wire
Emergent BioSolutions Co-Hosts Biopreparedness Co .. with the French High Committee for Civil Defense
[ Fri, Sep 09th 2011 ] - Market Wire
Growing Clinical Evidence the Focus of Accuray&ap .. 9;s TomoTherapy Asia User Education Symposium
[ Fri, Sep 09th 2011 ] - Market Wire
Centric Health Announces Investor Event to Provide Strategic Corporate Update
Thu, September 8, 2011
[ Thu, Sep 08th 2011 ] - Market Wire
Covidien annonce les temps forts de sa r©union avec les investisseurs
[ Thu, Sep 08th 2011 ] - Market Wire
Health Net Announces Appearance at Morgan Stanley Global Healthcare Conference
[ Thu, Sep 08th 2011 ] - Market Wire
Isis Pharmaceuticals Hosts Dr. John Kastelein to .. term Data Recently Presented at ESC Congress 2011
[ Thu, Sep 08th 2011 ] - Market Wire
NeoStem Announces Participation in Multiple September Conferences
[ Thu, Sep 08th 2011 ] - Market Wire
Amgen to Present at the Morgan Stanley Global Healthcare Conference
[ Thu, Sep 08th 2011 ] - Market Wire
Abbott Named to the Dow Jones Sustainability Inde .. ear in Recognition of Leading Corporate Citizensh
[ Thu, Sep 08th 2011 ] - Market Wire
DiagnoCure announces third quarter 2011 earnings results
[ Thu, Sep 08th 2011 ] - Market Wire
Diagnocure To Present At Rodman &; Renshaw Annual .. lobal Investment Conference On September 13, 2011
Wed, September 7, 2011
[ Wed, Sep 07th 2011 ] - Market Wire
Opexa to Present at the Rodman & Renshaw Annual G .. ent Conference - Healthcare on September 13, 2011
[ Wed, Sep 07th 2011 ] - Market Wire
American Medical Alert Corp. Announces Date for I .. reholders and Deadline for Submitting Shareholder
[ Wed, Sep 07th 2011 ] - Market Wire
Teva and Alcobra Announce Phase II Trial of Novel .. -Stimulant MG01CI for ADHD Meets Primary Endpoint
[ Wed, Sep 07th 2011 ] - Market Wire
Unigene Appoints Industry Veteran Theron (Ted) Odlaug as New Independent Director to Board
[ Wed, Sep 07th 2011 ] - Market Wire
International Stem Cell to Present at the Rodman .. nual Global Investment Conference on September 12
[ Wed, Sep 07th 2011 ] - Market Wire
Hi-Tech Pharmacal Reports Sales of $56.2 Million .. f $1.05 for the First Quarter Ended July 31, 2011

Exelixis Announces September 27th Webcast of Presentation at the JMP Securities Healthcare Conference


//health-fitness.news-articles.net/content/2011/ .. at-the-jmp-securities-healthcare-conference.html
Published in Health and Fitness on Wednesday, September 21st 2011 at 14:53 GMT by Market Wire   Print publication without navigation


SOUTH SAN FRANCISCO, Calif.--([ BUSINESS WIRE ])--Exelixis, Inc. (NASDAQ:EXEL) announced today that Michael Morrissey, PhD, the companya™s president and chief executive officer, will present at the JMP Securities Healthcare Conference at 11:30 a.m. EDT / 8:30 a.m. PDT on Tuesday, September 27, 2011, in New York. During the presentation, Dr. Morrissey will provide a general business update, review the most recent publicly available data for cabozantinib in castration-resistant prostate cancer, and discuss the pivotal trial plans and regulatory strategy for the compound.

The presentation will be webcast and may be accessed in the Event Calendar page under Investors at [ www.exelixis.com ].

About Exelixis

Exelixis, Inc. is a biotechnology company committed to developing small molecule therapeutics for the treatment of cancer. Exelixis is focusing its resources and development efforts exclusively on cabozantinib, its most advanced solely-owned product candidate, in order to maximize the therapeutic and commercial potential of this compound. Exelixis believes cabozantinib has the potential to be a high-quality, differentiated pharmaceutical product that can make a meaningful difference in the lives of patients. Exelixis has also established a portfolio of other novel compounds that it believes have the potential to address serious unmet medical needs. For more information, please visit the company's web site at [ www.exelixis.com ].


Publication Contributing Sources